BiotinâÂÂ(acetyl-CoA-carboxylase) ligase, more commonly known as BirA, is a 35kD enzyme found in prokaryotes, most notably Escherichia coli. It plays a central role in the metabolism of biotin (also known as vitamin B7) by performing two distinct functions: it acts as a biotin protein ligase (), catalyzing the covalent attachment of biotin to its target proteins, and as a transcriptional repressor, controlling the expression of the biotin biosynthesis (bio-)operon.
Due to the high specificity of its ligase activity and the exceptional strength of the resulting biotin-avidin interaction - the binding of biotin and avidin is among the strongest noncovalent interactions known -, BirA has been extensively repurposed as a powerful tool in molecular biology, proteomics, and biotechnology. Engineered variants of BirA are foundational to techniques for site-specific protein labeling and proximity-dependent identification of protein interaction networks.
The systematic name of this enzyme class is biotin:apo-[acetyl-CoA:carbon-dioxide ligase (ADP-forming)] ligase (AMP-forming). Other names in common use include:
It belongs to the family of ligases, specifically those forming carbon-nitrogen bonds as acid-D-amino-acid ligases (peptide synthases).
In its native host, BirA acts as a homeostatic regulator of biotin. BirA's primary catalytic function is to attach a molecule of D-biotin to a specific lysine residue on an acceptor protein. This post-translational modification is essential for the function of biotin-dependent carboxylases. In E. coli, the sole natural substrate for BirA is the Biotin Carboxyl Carrier Protein (BCCP), a subunit of the enzyme Acetyl-CoA Carboxylase (ACC).
The biotinylated ACC is critical for the first step of fatty acid synthesis: the carboxylation of acetyl-CoA to produce malonyl-CoA. The reaction proceeds as follows:<blockquote>Biotin + Apo-BCCP + ATP Holo-BCCP + AMP + PP<sub>i</sub></blockquote>Without a functional BirA, BCCP remains in its apo- (unbiotinylated) form, rendering ACC inactive and halting fatty acid synthesis, which is lethal to the cell. BirA also functions as a DNA-binding protein that represses the transcription of the bio-operon (bioABCDE), which contains the genes for the biotin synthesis pathway. This regulatory function is allosterically controlled by the concentration of the catalytic intermediate, biotinyl-5'-AMP.
The E. coli BirA protein is a homodimer, with each monomer having a molecular weight of approximately 35.4 kDa. Each monomer is composed of three distinct domains:
The transition from the ligase-competent to the repressor-competent state is driven by the binding of biotinyl-5'-AMP, which orders a flexible loop in the central domain. This change is allosterically transmitted to the N-terminal domain, causing it to lock into a fixed orientation that is optimal for dimerization and high-affinity DNA binding. The biotinylation reaction occurs in two discrete steps within the same active site:
BirA uses ATP to activate the carboxyl group of biotin, forming a high-energy mixed anhydride intermediate, biotinyl-5'-adenylate (biotinyl-5'-AMP), and releasing pyrophosphate (PP<sub>i</sub>). <blockquote>Biotin + ATP â Biotinyl-5'-AMP + PP<sub>i</sub> </blockquote>The activated biotinyl group is transferred from AMP to the õ-amino group of the specific target lysine residue on the acceptor protein (e.g., BCCP). This forms a stable amide bond. <blockquote>Biotinyl-5'-AMP + Apo-protein â Biotinylated-protein + AMP</blockquote>
The natural recognition sequence for BirA on BCCP has been minimized to a 15-amino-acid peptide, commonly known as the AviTag (sequence: GLNDIFEAQKIEWHE). By genetically fusing the AviTag to a protein of interest (POI), researchers can use BirA to specifically biotinylate that protein at a single, known site.